Ionolyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate)

The formulation supplies magnesium, potassium, sodium and acetate ions directly into the bloodstream. These ions replenish depleted stores, help maintain plasma osmolarity, support cellular enzymatic processes, nerve transmission and muscle contraction, and assist in stabilising acid‑base balance during intravenous therapy.

The dose of Ionolyte is determined by the prescribing clinician based on the patient’s electrolyte status, fluid needs and clinical condition. Healthcare professionals calculate the appropriate volume and rate of infusion according to individual therapeutic goals.

Safety data for Ionolyte in pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by the treating physician.

To order Ionolyte, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ionolyte provides a balanced combination of magnesium, potassium, sodium and acetate, whereas many alternatives such as Ringer's Lactate or Plasma‑Lyte contain calcium and lack magnesium. The choice depends on the specific electrolyte deficits and clinical scenario, with Ionolyte offering targeted magnesium and potassium supplementation.

Ionolyte should be stored at ambient temperature, kept in its original packaging, protected from direct light and moisture. Do not freeze the solution, and inspect the container for any signs of damage before use.

Ionolyte is administered intravenously, typically by slow infusion through a peripheral or central line. The solution may be given undiluted or diluted according to the prescribing information, and infusion rates are adjusted based on the patient’s electrolyte and fluid status.

Serious risks include severe hypermagnesemia or hyperkalemia, which can cause cardiac arrhythmias or arrest, as well as anaphylactic reactions and infection from contaminated solutions. Continuous monitoring of electrolyte levels and patient response is essential during therapy.

Ionolyte is contraindicated in patients with known hypersensitivity to any of its components, severe renal failure with inability to excrete excess electrolytes, existing hypermagnesemia or hyperkalemia, and in those where rapid fluid overload would be hazardous.